In our study, the expression of SCARA5 was controversial due to the decreased levels detected in RA biopsies by mass spectrometry, whereas the increased levels were observed in the stroma of inflamed biopsies by immunohistochemistry. Here, SCARA5 is linked to rheumatoid arthritis.